Mumps Vaccines: Current Challenges and Future Prospects

Iman Almansour1

  • 1Department of Epidemic Diseases Research, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.

Frontiers in Microbiology
|September 25, 2020
PubMed

Insights

Despite widespread vaccination, mumps outbreaks persist globally. This review examines current mumps vaccines, their limitations, and strategies for developing improved vaccines offering long-lasting protection against mumps virus.

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • Mumps infections have resurged globally despite decades of vaccination.
  • Outbreaks occur even in highly vaccinated populations, posing a public health threat.

Purpose of the Study:

  • To provide an immuno-biological perspective on mumps vaccines.
  • To review mumps virology, current vaccines, and immune responses.
  • To discuss limitations and propose strategies for improved mumps vaccine development.

Main Methods:

  • Literature review of mumps virology.
  • Analysis of licensed mumps vaccines and their immunogenicity.
  • Examination of epidemiological data on mumps outbreaks.
  • Discussion of challenges and future directions for vaccine development.

Main Results:

  • Current mumps vaccines face limitations in providing long-lasting protection.
  • Resurgence of mumps highlights the need for enhanced vaccine efficacy.
  • Understanding immune responses is crucial for next-generation vaccine design.

Conclusions:

  • An improved mumps vaccine offering durable protection is a priority.
  • Addressing current vaccine limitations is essential for controlling mumps outbreaks.
  • Future strategies should focus on developing vaccines with superior and sustained immunogenicity.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
50.5K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
747
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
854
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
610
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
16.7K